Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02927002
Other study ID # 2014-374
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 17, 2016
Last updated October 6, 2017
Start date October 2015
Est. completion date January 2018

Study information

Verified date October 2017
Source Laval University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to study the effect of noninvasive brain stimulation on decision-making and on brain activity in impulse control disorders.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 18
Est. completion date January 2018
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria:

- Impulse control disorders according to DSM-IV criteria

Exclusion Criteria:

- Other psychiatric disorders

- Contraindication to Non-invasive brain stimulation and MRI

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Noninvasive brain stimulation


Locations

Country Name City State
Canada Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Québec Quebec

Sponsors (1)

Lead Sponsor Collaborator
Laval University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in decision-making from pre to post stimulation assessed with the Balloon Analogue Risk Task 10 minutes before and immediately after the 30 minutes of non invasive brain stimulation
Secondary Changes in brain activity assessed between before and during stimulation measured with functional magnetic resonance (fMRI) 20 minutes before and immediately after the 30 minutes of non invasive brain stimulation
Secondary Neural metabolites concentrations measured with magnetic resonance spectroscopy (MRS) 20 minutes before and immediately after the 30 minutes of non invasive brain stimulation
Secondary Change in Craving from pre to post stimulation assessed with a single standardized scale 7 minutes before and 3 minutes after the end of the 30 minutes of non invasive brain stimulation
See also
  Status Clinical Trial Phase
Completed NCT01683253 - Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa Phase 4
Completed NCT01052831 - Naltrexone for Impulse Control Disorders in Parkinson's Disease Phase 4
Recruiting NCT06237868 - rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease N/A
Recruiting NCT05712057 - Neurostimulation Versus Therapy for Problems With Emotions N/A
Recruiting NCT03146130 - Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders Phase 3